STE financials
STERIS plc · end-of-day data as of Oct 16, 2026
STERIS plc
$222.66+4.3%
Buy · 9 analystsPT $276.53 +24.2%
STE reported revenue of $1.49B for the quarter ended Jun 30, 2026 (Q1 FY2027), up 7.3% from a year earlier. It posted diluted EPS of $2.04, free cash flow of $280M and a net margin of 13.4%.
Valuation
- P/E27.2x
- P/E vs own-12.6%
- P/E vs sector-3.3%
- FCF yield+4.3%
- Market cap$21.71B
Quarterly results
Q1 FY2027: Revenue +7.3% year over year, free cash flow 18.7% of revenue, operating margin 19.1%.
RevenueFree cash flow
| Q1 FY2027 | Jun 30, 2026 | $1.49B | 2.04 | $280M | 45.8% | 19.1% | 13.4% |
| Q4 FY2026 | Mar 31, 2026 | $1.59B | 2.24 | $245M | 43.9% | 19.9% | 13.9% |
| Q3 FY2026 | Dec 31, 2025 | $1.5B | 1.96 | $200M | 43.8% | 18.1% | 12.9% |
| Q2 FY2026 | Sep 30, 2025 | $1.46B | 1.94 | $201M | 44.2% | 18.4% | 13.1% |
| Q1 FY2026 | Jun 30, 2025 | $1.39B | 1.79 | $326M | 45.1% | 17.7% | 12.8% |
| Q4 FY2025 | Mar 31, 2025 | $1.48B | 1.48 | $190M | 43.3% | 14.6% | 9.8% |
| Q3 FY2025 | Dec 31, 2024 | $1.37B | 1.75 | $244M | 44.5% | 17.9% | 12.7% |
| Q2 FY2025 | Sep 30, 2024 | $1.33B | 1.51 | $149M | 43.6% | 16.5% | 11.3% |
| Q1 FY2025 | Jun 30, 2024 | $1.28B | 1.46 | $196M | 44.7% | 14.5% | 11.4% |
| Q4 FY2024 | Mar 31, 2024 | $1.12B | -0.01 | $163M | 40.2% | 22.0% | -0.1% |
| Q3 FY2024 | Dec 31, 2023 | $1.3B | 1.42 | $172M | 43.2% | 17.5% | 10.8% |
| Q2 FY2024 | Sep 30, 2023 | $1.24B | 1.16 | $62.8M | 44.1% | 15.5% | 9.3% |